SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 125 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $86 | +115.0% | 3,711 | +146.9% | 0.00% | – |
| Q2 2023 | $40 | +2.6% | 1,503 | 0.0% | 0.00% | – |
| Q1 2023 | $39 | 0.0% | 1,503 | 0.0% | 0.00% | – |
| Q4 2022 | $39 | -99.9% | 1,503 | 0.0% | 0.00% | – |
| Q3 2022 | $43,000 | +16.2% | 1,503 | 0.0% | 0.00% | – |
| Q2 2022 | $37,000 | -38.3% | 1,503 | +50.8% | 0.00% | – |
| Q1 2022 | $60,000 | -3.2% | 997 | 0.0% | 0.00% | – |
| Q4 2021 | $62,000 | -3.1% | 997 | 0.0% | 0.00% | – |
| Q3 2021 | $64,000 | -40.2% | 997 | -23.5% | 0.00% | – |
| Q2 2021 | $107,000 | +12.6% | 1,303 | 0.0% | 0.00% | – |
| Q1 2021 | $95,000 | +46.2% | 1,303 | +44.0% | 0.00% | – |
| Q4 2020 | $65,000 | +51.2% | 905 | 0.0% | 0.00% | – |
| Q3 2020 | $43,000 | +13.2% | 905 | 0.0% | 0.00% | – |
| Q2 2020 | $38,000 | – | 905 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480,558,000 | 31.49% |
| Consonance Capital Management LP | 1,199,339 | $98,838,000 | 11.90% |
| Boxer Capital, LLC | 2,075,905 | $171,075,000 | 6.04% |
| Perceptive Advisors | 9,699,824 | $799,362,000 | 5.19% |
| Orbimed Advisors | 6,044,266 | $498,108,000 | 5.04% |
| Samsara BioCapital, LLC | 169,852 | $13,998,000 | 1.73% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,375,775 | $113,378,000 | 1.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 195,117 | $16,080,000 | 1.09% |
| Artal Group S.A. | 500,000 | $41,205,000 | 0.84% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $46,032,000 | 0.82% |